164 related articles for article (PubMed ID: 1998960)
1. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil.
de Brauw LM; Marinelli A; van de Velde CJ; Hermans J; Tjaden UR; Erkelens C; de Bruijn EA
Cancer Res; 1991 Mar; 51(6):1694-700. PubMed ID: 1998960
[TBL] [Abstract][Full Text] [Related]
2. Isolated liver perfusion for regional chemotherapy in rats.
Xing X; Li H
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):388-92. PubMed ID: 17690035
[TBL] [Abstract][Full Text] [Related]
3. Melphalan antitumor efficacy and hepatotoxicity: the effect of variable infusion duration in the hepatic artery.
Rothbarth J; Woutersen RA; Sparidans RW; van de Velde CJ; Mulder GJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):1098-103. PubMed ID: 12606622
[TBL] [Abstract][Full Text] [Related]
4. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
[TBL] [Abstract][Full Text] [Related]
5. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
6. Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver.
Harris BE; Song RL; Soong SJ; Diasio RB
Cancer Res; 1989 Dec; 49(23):6610-4. PubMed ID: 2819711
[TBL] [Abstract][Full Text] [Related]
7. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH
Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009
[TBL] [Abstract][Full Text] [Related]
8. In vivo isolated liver perfusion technique in a rat hepatic metastasis model: 5-fluorouracil concentrations in tumor tissue.
de Brauw LM; van de Velde CJ; Tjaden UR; de Bruijn EA; Bell AV; Hermans J; Zwaveling A
J Surg Res; 1988 Feb; 44(2):137-45. PubMed ID: 3339874
[TBL] [Abstract][Full Text] [Related]
9. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
[TBL] [Abstract][Full Text] [Related]
10. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
Wagner JG; Gyves JW; Stetson PL; Walker-Andrews SC; Wollner IS; Cochran MK; Ensminger WD
Cancer Res; 1986 Mar; 46(3):1499-506. PubMed ID: 3943107
[TBL] [Abstract][Full Text] [Related]
11. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
[TBL] [Abstract][Full Text] [Related]
12. High mitomycin C concentration in tumour tissue can be achieved by isolated liver perfusion in rats.
Marinelli A; Pons DH; Vreeken JA; Nagesser SK; Kuppen PJ; Tjaden UR; van de Velde CJ
Cancer Chemother Pharmacol; 1991; 28(2):109-14. PubMed ID: 1905590
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy.
Remick SC; Benson AB; Weese JL; Willson JK; Ramirez G; Wirtanen GW; Alberti DB; Nieting LM; Tutsch KD; Fischer PH
Cancer Res; 1989 Nov; 49(22):6437-42. PubMed ID: 2804987
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in rats.
Marinelli A; van de Velde CJ; Kuppen PJ; Franken HC; Souverijn JH; Eggermont AM
Br J Cancer; 1990 Dec; 62(6):891-6. PubMed ID: 2124136
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 5-fluorouracil in rabbits in experimental regional chemotherapy.
Kar R; Cohen RA; Terem TM; Nahabedian MY; Wile AG
Cancer Res; 1986 Sep; 46(9):4491-5. PubMed ID: 3731104
[TBL] [Abstract][Full Text] [Related]
17. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
[TBL] [Abstract][Full Text] [Related]
18. Dose and flow dependence of 5-fluorouracil elimination by the isolated perfused rat liver.
Warren BS; LaCreta FP; Kornhauser DM; Williams WM
Cancer Res; 1987 Oct; 47(20):5261-5. PubMed ID: 3652033
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
20. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study.
Tono T; Hasuike Y; Ohzato H; Takatsuka Y; Kikkawa N
Cancer; 2000 Apr; 88(7):1549-56. PubMed ID: 10738212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]